Companies Carrick Therapeutics

Fighting aggressive cancers


Carrick Therapeutics is developing a range of treatments that aim to slow down or impede the progress of the most aggressive forms of cancer.

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more


Read More